ArticleCancer immunology, immunotherapy : CII2005

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.

Jasmin Dittmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.